Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only

计划入组 80 人 · 首次发布于 2019 年 11 月 1 日

Endoscopy Assisted Probing Versus Simple Probing in Primary Congenital Nasolacrimal Duct Obstruction

计划入组 320 人 · 首次发布于 2017 年 8 月 8 日

The Factors That Affected the Outcome of Treatment of Congenital Nasolacrimal Duct Obstruction

计划入组 800 人 · 首次发布于 2014 年 3 月 7 日

congenital hyperinsulinism therapeutic

congenital liver disease therapy

CRX gene therapy (Leber congenital amaurosis)

OncoSil Medical Ltd

Oventus Medical Ltd

VentriPoint Diagnostics Ltd

Age Matters: Tailoring Treatment for Congenital Nasolacrimal Duct Obstruction in Children

SAFIR-ABC10 Trial: Precision Medicine Approach Aims to Extend Survival in Bile Duct Cancer

FDA Panel Rejects Ocaliva's Full Approval for Primary Biliary Cholangitis